CMRX $2.10 in cash and no debt / enough to sustain through 2026 smart investors / Insiders are buying as well / year end tax loss harvesting is almost done and I believe biotechs will run fast in jan / feb
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.94 USD
−82.09 M USD
324.00 K USD
80.14 M
About Chimerix, Inc.
Sector
CEO
Michael T. Andriole
Headquarters
Durham
Website
Founded
2000
FIGI
BBG000R33651
Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC.
CMRX waiting for news Now we just need some news to get dropped. Some positive ones, and we are ready to do.
target 2.90 ( 1 to 5 months )Good Technical ( Nice Breakout ) and Good Fundamental ( Good Result ) , So Target 2.90 , Duration 1 to 5 months.
Chimerix Awarded BARDA Contract for TEMBEXACMRX: Chimerix, Inc.
2022-08-29 10:45:00 Chimerix Awarded BARDA Contract for TEMBEXA as Medical Countermeasure for Smallpox
Chimerix Announces Positive Topline Results for ONC201 in RecurrCMRX: Chimerix, Inc.
2021-11-04 07:00:00
Chimerix Announces Positive Topline Results for ONC201 in Recurrent H3 K27M-mutant Glioma
CMRX 2/7/2020Analysis-
Daily chart- After long downtrend, price has been in sideways market between 1.24-3.38 for 638 days. After making a move to resistance on July2020, price fell and found support from 200 MA then working itself back to resistance and finally breaking out. After breakout of 40%, price pulled
CMRX descending wedge formedsimple wedge formed in order to add onto my long term hold once we hopefully bounce off of the 3.26 fib level
CMRX daily 160% gains setup(STOCKS)before we kick start the update. your upvotes/subs are appreciated.
Why get subbed to to me on Tradingview?
-15+ years real live trading experience
-TOP Author on TradingView
-professional chart break downs
-key levels
-no junk on my charts
-frequent updates
-covering FX/crypto/US stocks
-24/7
$CMRX Chimerix Inc Moving big pore market - Covid-19DURHAM, N.C., April 29, 2020 (GLOBE NEWSWIRE) -- Chimerix (CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced the Company’s initiation of a Phase 2/3 study of dociparstat sodium (DSTAT) in COVID-19 patie
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CMRX is 2.99 USD — it has increased by 4.91% in the past 24 hours. Watch Chimerix, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Chimerix, Inc. stocks are traded under the ticker CMRX.
CMRX stock has fallen by −2.61% compared to the previous week, the month change is a 245.66% rise, over the last year Chimerix, Inc. has showed a 218.09% increase.
We've gathered analysts' opinions on Chimerix, Inc. future price: according to them, CMRX price has a max estimate of 11.00 USD and a min estimate of 6.00 USD. Watch CMRX chart and read a more detailed Chimerix, Inc. stock forecast: see what analysts think of Chimerix, Inc. and suggest that you do with its stocks.
CMRX reached its all-time high on Aug 5, 2015 with the price of 58.04 USD, and its all-time low was 0.75 USD and was reached on Aug 13, 2024. View more price dynamics on CMRX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CMRX stock is 14.27% volatile and has beta coefficient of −0.96. Track Chimerix, Inc. stock price on the chart and check out the list of the most volatile stocks — is Chimerix, Inc. there?
Today Chimerix, Inc. has the market capitalization of 268.91 M, it has decreased by −5.70% over the last week.
Yes, you can track Chimerix, Inc. financials in yearly and quarterly reports right on TradingView.
Chimerix, Inc. is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
CMRX earnings for the last quarter are −0.26 USD per share, whereas the estimation was −0.24 USD resulting in a −10.17% surprise. The estimated earnings for the next quarter are −0.25 USD per share. See more details about Chimerix, Inc. earnings.
Chimerix, Inc. revenue for the last quarter amounts to 26.00 K USD, despite the estimated figure of 312.00 K USD. In the next quarter, revenue is expected to reach 300.60 K USD.
CMRX net income for the last quarter is −22.88 M USD, while the quarter before that showed −20.68 M USD of net income which accounts for −10.61% change. Track more Chimerix, Inc. financial stats to get the full picture.
No, CMRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 72.00 employees. See our rating of the largest employees — is Chimerix, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Chimerix, Inc. EBITDA is −92.84 M USD, and current EBITDA margin is −28.72 K%. See more stats in Chimerix, Inc. financial statements.
Like other stocks, CMRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Chimerix, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Chimerix, Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Chimerix, Inc. stock shows the buy signal. See more of Chimerix, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.